ReviewInfectious diseases and therapy2026
Epidemiology of Acute Cystitis or Afebrile Urinary Tract Infection in Adult Men: A Systematic Literature Review.
Review in Infectious diseases and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUpdated Infectious Diseases Society of America guidelines for urinary tract infections (UTIs) have reclassified UTI in men without signs of systemic infection, with/without anatomical abnormalities of the urinary tract from complicated UTI to uncomplicated UTI (uUTI), which has implications for diagnosis and management. We conducted a systematic literature review to describe epidemiologic outcomes (disease incidence and prevalence), recurrence, and antimicrobial resistance (AMR) rates of afebrile UTI or acute cystitis in adult men without signs of systemic infection.
methodsSystematic searches for English language articles published January 2011-May 2023 were conducted in MEDLINE, MEDLINE In-Process, and Embase databases via OvidSP. Grey literature sources were also reviewed. Publications were evaluated by two independent reviewers and selected using PICOS.
resultsSearches yielded 1025 records. After screening, five studies (2012-2020) from Japan, the Netherlands, Turkey, Uganda, and the USA were eligible. Sample sizes ranged between 18 and 4876 patients; case definitions varied. Median age was 44-71 years across four studies. In the Dutch study, uUTI incidence in male patients was 6.5/1000 person-years, increasing with age. Escherichia coli was the uropathogen in 32.9-94% of patients. Nitrofurantoin (56.0%) and fluoroquinolones (62.8%) were the most common antibiotic treatments in the Dutch and Japanese studies, respectively. In the Turkish study, AMR for Escherichia coli was > 29% for all drugs tested (cefpodoxime, amoxicillin/clavulanic acid, trimethoprim/sulfamethoxazole, ciprofloxacin) except fosfomycin (11.8%). No eligible studies assessed multidrug resistance. Only two studies investigated UTI recurrence, with different definitions.
conclusionsThe low number of studies identified, coupled with variations in study design, inclusion criteria, and uUTI definitions, negated effectively describing acute cystitis epidemiology in men. There is a need for large, population-based studies, leveraging standard definitions for acute cystitis/afebrile UTI and focusing on AMR burden and recurrence rates to positively inform and improve clinical care in men with uUTI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.